Which of the following is a secondary mediator of anaphylaxis?

Eosinophilic chemotactic factor

Which of the following is/are characteristic features of chronic inflammation?

Tissue fibrosis and lymphocyte infiltration

Increased blood flow (hyperemia)

Presence of fluid accumulation (edema) in tissues

Inflammation and Repair | Pathology

🔥 The Inflammatory Arsenal: Your Body's Emergency Response System

Every cut, infection, and injury triggers an ancient defense system that can save your life or, when dysregulated, destroy tissue and drive chronic disease. You'll master how your body deploys chemical signals to dilate vessels, recruit immune cells through precise adhesion cascades, eliminate threats, and orchestrate repair-or fail to resolve, creating pathology. This lesson builds your clinical eye for recognizing inflammatory patterns, from the molecular mediators commanding each phase to the vascular and cellular choreography that determines whether healing succeeds or inflammation becomes the enemy itself.

The inflammatory response represents one of medicine's most fundamental processes, governing everything from wound healing timelines to autoimmune disease progression. Master these mechanisms, and you possess the framework for understanding pathology across every organ system.

📌 Remember: SHARP defines inflammation's cardinal signs - Swelling, Heat, Ache (dolor), Redness, Power loss (functio laesa). Each sign reflects specific vascular and cellular events with measurable parameters.

The Inflammatory Response Hierarchy

Immediate Response (0-30 minutes)
- Vasoactive mediator release: histamine peaks at 5-10 minutes
- Vascular permeability increases 3-5 fold within 15 minutes
- Complement activation: C3a/C5a levels rise 200-400%
  - Classical pathway: antibody-mediated, 1-2 minutes
  - Alternative pathway: direct activation, 30 seconds
  - Lectin pathway: mannose-binding, 2-5 minutes
Early Cellular Phase (30 minutes-6 hours)
- Neutrophil recruitment: peak at 2-4 hours
- Selectin-mediated rolling: velocity drops from 1000 to 5 μm/sec
- Integrin activation: firm adhesion within 30-60 seconds
  - P-selectin expression: increases 10-fold in 5 minutes
  - ICAM-1 upregulation: peaks at 4-6 hours
Late Cellular Phase (6-48 hours)
- Monocyte infiltration: peaks at 24-48 hours
- Lymphocyte recruitment: begins at 12-24 hours
- Resolution mediator production: lipoxins peak at 24 hours

Mediator Class	Peak Time	Duration	Primary Effect	Clinical Marker
Histamine	5-10 min	30-60 min	Vasodilation, permeability	Immediate wheal response
Prostaglandins	15-30 min	2-6 hours	Pain, fever, vasodilation	PGE2 >200 pg/mL
Leukotrienes	30-60 min	4-12 hours	Bronchoconstriction, chemotaxis	LTC4 >50 pg/mL
Cytokines	1-4 hours	12-72 hours	Systemic effects, cell activation	IL-1β >10 pg/mL
Complement	2-5 min	30-120 min	Membrane attack, chemotaxis	C3a >200 ng/mL

💡 Master This: Inflammation timing predicts therapeutic windows - anti-histamines work best within 30 minutes, NSAIDs most effective at 1-4 hours, and corticosteroids optimal after 6-12 hours when transcriptional effects dominate.

The precision of inflammatory timing enables targeted therapeutic interventions that maximize efficacy while minimizing adverse effects, setting the foundation for understanding how cellular recruitment orchestrates tissue defense.

🔥 The Inflammatory Arsenal: Your Body's Emergency Response System

Acute Inflammation: Vascular Events

Systemic Effects of Inflammation

⚡ Cellular Command Center: The Inflammatory Cell Brigade

The Cellular Response Architecture

Neutrophils: The First Responders (Peak: 2-6 hours)
- Lifespan: 6-12 hours in tissues
- Recruitment rate: 10^9 cells/hour during acute inflammation
- Killing mechanisms: 4 primary pathways
  - Phagocytosis: engulfs 5-20 bacteria per cell
  - Degranulation: releases 300+ antimicrobial proteins
  - NET formation: extracellular DNA traps, 15-30 minutes
  - Respiratory burst: superoxide production increases 100-fold
Macrophages: The Tissue Guardians (Peak: 24-72 hours)
- Lifespan: weeks to months in tissues
- Phenotype switching: M1 (pro-inflammatory) to M2 (repair)
- Phagocytic capacity: 100+ apoptotic cells per macrophage
  - M1 markers: iNOS, TNF-α, IL-1β production
  - M2 markers: Arginase-1, IL-10, TGF-β secretion
  - Phenotype transition: occurs at 48-72 hours

📌 Remember: NETS describes neutrophil extracellular traps - Neutrophil Extracellular Traps Snare pathogens using DNA, histones, and antimicrobial proteins. Formation requires 15-30 minutes and indicates severe inflammatory activation.

Cell Type	Peak Recruitment	Lifespan	Primary Function	Failure Consequence
Neutrophils	2-6 hours	6-12 hours	Bacterial killing, NET formation	Abscess formation, sepsis
Macrophages	24-72 hours	Weeks-months	Phagocytosis, tissue repair	Chronic inflammation, fibrosis
Eosinophils	48-96 hours	8-12 days	Parasite defense, allergy	Tissue damage, asthma
Lymphocytes	3-7 days	Years	Adaptive immunity, memory	Autoimmunity, immunodeficiency
Mast Cells	Resident	Months	Immediate hypersensitivity	Anaphylaxis, chronic urticaria

Granule proteins: 4 major cytotoxic proteins
Degranulation triggers: IL-5 >50 pg/mL, eotaxin >100 pg/mL
Tissue damage potential: major basic protein causes epithelial destruction
- Normal blood count: <350 cells/μL
- Mild eosinophilia: 350-1,500 cells/μL
- Severe eosinophilia: >5,000 cells/μL (tissue damage risk)

⭐ Clinical Pearl: Eosinophil count >1,500 cells/μL with tissue infiltration indicates hypereosinophilic syndrome with organ damage risk >80%. Cardiac involvement occurs in 60% of cases with endomyocardial fibrosis.

💡 Master This: Neutrophil predominance >80% suggests bacterial infection, while lymphocyte predominance >60% indicates viral or chronic inflammation. Eosinophil predominance >20% points to parasitic, allergic, or drug-induced inflammation.

Understanding cellular recruitment patterns enables precise diagnostic discrimination and therapeutic timing, connecting to how these cells orchestrate the complex molecular mediator networks that amplify or resolve inflammatory responses.

⚡ Cellular Command Center: The Inflammatory Cell Brigade

Acute Inflammation: Cellular Events

Chronic Inflammation

🎯 Molecular Mediator Networks: The Chemical Command System

The Mediator Response Hierarchy

Immediate Mediators (Seconds to Minutes)
- Histamine: mast cell degranulation within 30 seconds
  - H1 receptors: vasodilation, increased permeability
  - H2 receptors: gastric acid secretion, cardiac effects
  - Peak plasma levels: 5-10 minutes, returns to baseline by 60 minutes
  - Therapeutic window: antihistamines most effective <30 minutes
- Complement Components: activation within 1-5 minutes
  - C3a/C5a: anaphylatoxins, mast cell degranulation
  - C5a: neutrophil chemotaxis, 100-fold more potent than C3a
  - MAC (C5b-9): membrane attack complex, cell lysis
  - Normal C3 levels: 90-180 mg/dL, consumption drops >50% in active inflammation

Early Mediators (Minutes to Hours)
- Arachidonic Acid Metabolites: peak production 15-60 minutes
  - COX pathway: prostaglandins, thromboxanes
  - LOX pathway: leukotrienes, lipoxins
  - PGE2: vasodilation, pain, fever >38.5°C
  - LTC4/LTD4: bronchoconstriction, 1000x more potent than histamine

📌 Remember: PILL describes prostaglandin effects - Pain sensitization, Inflammation amplification, Lower platelet aggregation (PGI2), Lower gastric protection (PGE2 inhibition causes ulcers).

Mediator	Peak Time	Half-Life	Primary Effect	Therapeutic Target
Histamine	30 seconds	2-3 minutes	Immediate vasodilation	H1/H2 antagonists
PGE2	15-30 min	5-10 minutes	Pain, fever, vasodilation	COX inhibitors
LTC4	30-60 min	10-30 minutes	Bronchoconstriction	Leukotriene antagonists
TNF-α	1-4 hours	20-30 minutes	Systemic inflammation	Anti-TNF biologics
IL-1β	2-6 hours	6-8 hours	Fever, acute phase response	IL-1 receptor antagonists

Cytokines: transcriptional regulation, sustained effects
- TNF-α: peak at 1-4 hours, induces other cytokines
- IL-1β: fever, acute phase proteins, >39°C within 2 hours
- IL-6: hepatic acute phase response, CRP elevation
- IL-10: anti-inflammatory, resolution promotion
Chemokines: directional cell recruitment
- IL-8 (CXCL8): neutrophil chemotaxis, peak at 4-8 hours
- MCP-1 (CCL2): monocyte recruitment, sustained elevation
- Eotaxin (CCL11): eosinophil chemotaxis, allergic responses

⭐ Clinical Pearl: TNF-α levels >50 pg/mL predict severe inflammatory response with >85% sensitivity. Levels >200 pg/mL indicate systemic inflammatory response syndrome (SIRS) with shock risk >60%.

💡 Master This: COX-1 inhibition causes gastric ulcers (loss of protective PGE2), while COX-2 selective inhibition reduces inflammation without gastric toxicity but increases cardiovascular risk through PGI2 suppression.

The mediator cascade timing creates therapeutic windows where early intervention with specific inhibitors prevents amplification cascades that lead to tissue damage and chronic inflammation, connecting directly to how these molecular signals drive the vascular changes that create clinical signs.

🎯 Molecular Mediator Networks: The Chemical Command System

Chemical Mediators of Inflammation

🌊 Vascular Response Patterns: The Hemodynamic Theater

The Vascular Response Architecture

Vasodilation Cascade (Peak: 5-15 minutes)
- Arteriolar diameter: increases 2-4 fold within 5 minutes
- Blood flow: increases 3-10 fold in affected tissues
- Mediator hierarchy: histamine → PGE2 → nitric oxide
  - Histamine: immediate response, 30 seconds to 5 minutes
  - PGE2: sustained response, 15 minutes to 4 hours
  - Nitric oxide: endothelial-dependent, continuous production
  - Local temperature: increases 2-4°C above baseline
Permeability Changes (Peak: 15-30 minutes)
- Endothelial gap formation: intercellular spaces increase 5-20 fold
- Protein extravasation: albumin leakage increases 10-50 fold
- Hydrostatic pressure: increases 15-25 mmHg in postcapillary venules
  - Normal capillary pressure: 25-35 mmHg
  - Inflammatory pressure: 40-60 mmHg
  - Filtration coefficient: increases 100-1000 fold

📌 Remember: FLOW describes vascular changes - Flow increases (vasodilation), Leakage increases (permeability), Oncotic pressure drops (protein loss), Water accumulates (edema formation).

Vascular Parameter	Normal Value	Inflammatory Change	Time Course	Clinical Sign
Arteriolar diameter	20-50 μm	↑ 2-4 fold	5-15 minutes	Erythema, heat
Capillary pressure	25-35 mmHg	↑ to 40-60 mmHg	15-30 minutes	Edema formation
Permeability coefficient	Baseline	↑ 100-1000 fold	15-60 minutes	Protein extravasation
Blood flow velocity	0.5-1.0 mm/sec	↑ 3-10 fold initially	5-30 minutes	Pulsatile erythema
Plasma protein concentration	6-8 g/dL	↓ 20-40% locally	30-120 minutes	Tissue swelling

Flow velocity reduction: drops to 10-20% of normal
Hematocrit increase: local concentration rises 40-60%
Leukocyte margination: white cells line vessel walls
- Normal flow: leukocytes in central stream
- Inflammatory stasis: leukocytes along endothelium
- Rolling velocity: decreases from 1000 to 5 μm/sec

Pressure Gradient Changes (Sustained: 2-24 hours)
- Interstitial pressure: increases from -3 to +5 mmHg
- Lymphatic drainage: increases 10-20 fold initially
- Oncotic pressure gradient: reverses in severe inflammation
  - Normal gradient: plasma > interstitium by 15-20 mmHg
  - Inflammatory reversal: interstitium > plasma in severe cases

⭐ Clinical Pearl: Pitting edema indicates interstitial pressure >5 mmHg with protein concentration >3 g/dL. Non-pitting edema suggests lymphatic obstruction or high-protein exudate with >4 g/dL protein.

💡 Master This: Erythema that blanches indicates vasodilation without vessel damage, while non-blanching erythema suggests extravasated red blood cells or vessel wall necrosis requiring different therapeutic approaches.

Vascular response patterns create the foundation for understanding how cellular recruitment follows specific adhesion cascades that determine which cell types reach inflamed tissues and when therapeutic interventions can modify inflammatory outcomes.

🌊 Vascular Response Patterns: The Hemodynamic Theater

Acute Inflammation: Vascular Events

🎪 Cellular Recruitment Choreography: The Adhesion Cascade

The Recruitment Sequence Architecture

Step 1: Capture and Rolling (Velocity: 1000 → 50 μm/sec)
- Selectin-mediated interactions: low-affinity, high-capacity binding
- P-selectin: stored in Weibel-Palade bodies, mobilized in 5 minutes
- E-selectin: transcriptionally induced, peaks at 4-6 hours
- L-selectin: constitutively expressed on leukocytes
  - Rolling velocity: decreases 20-fold from free flow
  - Contact duration: increases from milliseconds to seconds
  - Shear stress threshold: effective at 1-10 dynes/cm²

Step 2: Activation and Firm Adhesion (Duration: 30-60 seconds)
- Chemokine gradient recognition: G-protein coupled receptor activation
- Integrin conformational change: low → high affinity transition
- LFA-1 (CD11a/CD18): binds ICAM-1, universal leukocyte adhesion
- Mac-1 (CD11b/CD18): neutrophil-specific, complement receptor
  - Integrin activation: occurs within 10-30 seconds
  - Adhesion strength: increases 1000-fold over selectin binding
  - Shear resistance: withstands >100 dynes/cm²

📌 Remember: SAIL describes the adhesion cascade - Selectin capture, Activation by chemokines, Integrin firm adhesion, Leukocyte transmigration. Each step requires specific molecular interactions with distinct therapeutic targets.

Adhesion Step	Key Molecules	Time Course	Velocity Change	Therapeutic Target
Capture	P/E/L-selectin	Seconds	1000 → 50 μm/sec	Selectin antagonists
Rolling	Selectin/ligand	Minutes	50 → 5 μm/sec	Fucoidin, sialyl Lewis
Activation	Chemokines/GPCR	10-30 seconds	Deceleration	Chemokine receptor blockers
Firm adhesion	Integrins/ICAM	30-60 seconds	Complete arrest	Anti-integrin antibodies
Transmigration	PECAM-1, JAMs	2-5 minutes	Tissue entry	Junction modulators

Paracellular route: 95% of leukocytes use intercellular junctions
Transcellular route: 5% traverse through endothelial cell body
PECAM-1 (CD31): homophilic interactions guide junction passage
JAM proteins: junctional adhesion molecules, barrier regulation
- Junction width: expands from 20 nm to 200-500 nm
- Transmigration rate: 1-5 cells/minute per 100 μm vessel length
- Basement membrane: **degraded by matrix metalloproteinases

Step 4: Tissue Migration (Velocity: 10-50 μm/minute)
- Chemotactic gradient following: directional migration toward source
- Integrin-mediated traction: β1 and β2 integrins bind matrix
- Proteolytic path creation: MMPs clear tissue barriers
  - Migration speed: varies by cell type and tissue density
  - Neutrophils: fastest, 20-50 μm/minute
  - Monocytes: moderate, 10-30 μm/minute
  - Lymphocytes: slowest, 5-15 μm/minute

⭐ Clinical Pearl: LAD (Leukocyte Adhesion Deficiency) patients lack functional β2 integrins, causing recurrent bacterial infections with neutrophil counts >50,000/μL but no pus formation due to failed tissue recruitment.

💡 Master This: Selectin deficiency causes mild bleeding (platelet adhesion defects) and recurrent infections, while integrin deficiency causes severe immunodeficiency with life-threatening bacterial infections but normal platelet function.

The adhesion cascade precision enables targeted anti-inflammatory therapies that selectively block specific recruitment steps, connecting to how different inflammatory patterns create distinct clinical presentations requiring pattern-specific therapeutic approaches.

🎪 Cellular Recruitment Choreography: The Adhesion Cascade

Acute Inflammation: Cellular Events

🔄 Resolution and Repair Networks: The Healing Command Center

The Resolution Program Architecture

Active Resolution Initiation (Peak: 12-24 hours)
- Lipoxin A4 (LXA4): "braking signal" for neutrophil recruitment
- Resolvin E1 (RvE1): promotes neutrophil apoptosis and clearance
- Protectin D1 (PD1): neuroprotective, anti-inflammatory
- Maresin 1 (MaR1): macrophage-derived, tissue regeneration
  - LXA4 production: peaks at 12-24 hours after inflammation onset
  - Resolution index: LXA4:LTB4 ratio >1 indicates active resolution
  - Neutrophil apoptosis: increases 5-10 fold with resolution mediators

Efferocytosis Enhancement (Peak: 24-48 hours)
- "Find-me" signals: ATP, UTP, fractalkine from apoptotic cells
- "Eat-me" signals: phosphatidylserine exposure on apoptotic membranes
- Macrophage reprogramming: M1 → M2 phenotype switch
- Clearance capacity: each macrophage engulfs 5-20 apoptotic neutrophils
  - Efferocytosis efficiency: >95% in successful resolution
  - Failed clearance: <80% efficiency leads to secondary necrosis
  - Anti-inflammatory switch: occurs within 2-4 hours of efferocytosis

📌 Remember: CLEAR describes resolution mechanisms - Cessation of neutrophil recruitment, Lipoxin production, Efferocytosis activation, Anti-inflammatory cytokines, Repair program initiation.

Resolution Phase	Key Mediators	Time Course	Cellular Events	Failure Consequence
Initiation	LXA4, RvE1	12-24 hours	Neutrophil recruitment stops	Persistent neutrophilia
Clearance	PS, MFG-E8	24-48 hours	Apoptotic cell removal	Secondary necrosis
Repair	TGF-β, PDGF	48-96 hours	Tissue regeneration begins	Chronic inflammation
Restoration	IL-10, TGF-β	3-7 days	Normal function returns	Fibrosis, dysfunction

Growth factor release: PDGF, TGF-β, VEGF from activated macrophages
Angiogenesis initiation: new vessel formation within 72 hours
Fibroblast recruitment: collagen synthesis begins day 3-5
Epithelial regeneration: stem cell activation and proliferation
- VEGF levels: increase 10-50 fold during repair phase
- Collagen synthesis: peaks at 7-14 days post-injury
- Tensile strength: reaches 80% of normal by 6-8 weeks

Resolution Biomarkers (Monitoring: Days to weeks)
- Resolution indices: quantitative measures of healing progress
- Neutrophil clearance: >90% reduction from peak levels
- Pro-resolving mediator ratios: LXA4:LTB4 >1, RvE1:PGE2 >0.5
  - CRP normalization: <3 mg/L indicates systemic resolution
  - ESR return: <20 mm/hr suggests inflammatory resolution
  - Tissue function: >90% baseline indicates successful healing

⭐ Clinical Pearl: Resolution index <0.5 (pro-inflammatory:pro-resolving mediator ratio) predicts chronic inflammation development with >80% accuracy. Early intervention with omega-3 fatty acids can restore resolution capacity.

💡 Master This: Failed efferocytosis creates secondary necrosis with damage-associated molecular patterns (DAMPs) that perpetuate inflammation. Therapeutic enhancement of macrophage clearance prevents chronic inflammatory diseases.

Resolution network mastery enables predictive medicine where early resolution biomarkers guide therapeutic decisions to promote healing rather than simply suppress inflammation, creating the foundation for precision inflammatory medicine.

🔄 Resolution and Repair Networks: The Healing Command Center

Resolution of Inflammation

Wound Healing

🎯 Clinical Mastery Arsenal: Inflammatory Pattern Recognition

Essential Pattern Recognition Framework

Acute Inflammatory Signatures (0-72 hours)
- Neutrophil predominance: >80% of inflammatory cells
- Rapid onset: symptoms develop within 6-24 hours
- High fever: >38.5°C with rigors
- Elevated acute phase: CRP >100 mg/L, ESR >50 mm/hr
  - Bacterial pattern: Left shift, toxic granulation
  - Viral pattern: Lymphocyte predominance after 48 hours
  - Allergic pattern: Eosinophil count >10%

📌 Remember: RAPID identifies acute inflammation - Red, hot, swollen, Acute onset <24 hours, Pain prominent, Increased WBC >15,000, Dominant neutrophils >80%.

Pattern Type	Onset	Dominant Cell	Key Markers	Clinical Examples
Acute Bacterial	<24 hours	Neutrophils >80%	CRP >100 mg/L	Pneumonia, cellulitis
Acute Viral	24-72 hours	Lymphocytes >60%	Normal CRP	Viral hepatitis, myocarditis
Chronic Active	>2 weeks	Mixed cellular	ESR >50 mm/hr	Rheumatoid arthritis
Granulomatous	Weeks-months	Epithelioid cells	ACE elevated	Sarcoidosis, tuberculosis
Allergic	Minutes-hours	Eosinophils >10%	IgE >1000 IU/mL	Anaphylaxis, drug allergy

Macrophage/lymphocyte predominance: >70% of inflammatory cells
Tissue remodeling: fibrosis, angiogenesis, architectural changes
Systemic effects: weight loss, fatigue, anemia of chronic disease
Persistent elevation: ESR >30 mm/hr, CRP >10 mg/L
- Autoimmune pattern: ANA positive, complement consumption
- Granulomatous pattern: Epithelioid cells, giant cells
- Neoplastic pattern: Atypical cells, monoclonal populations

Resolution Assessment Framework (Days to weeks)
- Clinical improvement: symptom reduction >50% within 48-72 hours
- Laboratory normalization: CRP reduction >50% within 5-7 days
- Functional restoration: return to baseline activity within 1-2 weeks
  - Successful resolution: all parameters normalize
  - Incomplete resolution: persistent elevation of inflammatory markers
  - Failed resolution: progression to chronic inflammation

⭐ Clinical Pearl: CRP reduction <50% after 72 hours of appropriate therapy predicts treatment failure with >85% accuracy. Alternative diagnosis or resistant pathogen should be considered.

💡 Master This: Eosinophil count >1,500/μL with tissue infiltration indicates hypereosinophilic syndrome requiring immediate evaluation for cardiac involvement (occurs in 60% of cases) and potential organ damage.

Therapeutic Timing Optimization

Early Intervention Windows (0-6 hours)
- Antihistamines: maximum efficacy within 30 minutes
- Corticosteroids: genomic effects require 4-6 hours
- NSAIDs: optimal timing at 1-4 hours when prostaglandin synthesis peaks
Resolution Enhancement (12-48 hours)
- Omega-3 supplementation: promotes specialized pro-resolving mediators
- Macrophage activation: enhances efferocytosis capacity
- Antioxidant support: prevents resolution failure

This clinical mastery framework enables precision inflammatory medicine where pattern recognition drives targeted interventions that optimize healing outcomes while minimizing therapeutic complications and preventing chronic inflammatory disease development.